Labeled EGFr-TK irreversible inhibitor (ML03): In vitro and...

International Journal of Cancer 2002 Vol. 101; Iss. 4

Labeled EGFr-TK irreversible inhibitor (ML03): In vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drug

Giuseppina Ortu, Iris Ben-David, Yulia Rozen, Nanette M.T. Freedman, Roland Chisin, Alexander Levitzki, Eyal Mishani
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
101
Year:
2002
Language:
english
Pages:
11
DOI:
10.1002/ijc.10619
File:
PDF, 441 KB
english, 2002
Conversion to is in progress
Conversion to is failed